NCT04507282View on ClinicalTrials.gov

Eosinophil and Anticoagulation in COVID-19 Patients

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

May 15, 2020

Primary Completion Date

July 1, 2020

Study Completion Date

July 15, 2020

Conditions
COVID-19
Interventions
DRUG

LMWH

COVID 19 positive patients anticogulation level, subprophylactic level and prophylactic level

Trial Locations (1)

16310

Bursa Yüksek İhtisas Hastanesi, Yıldırım

All Listed Sponsors
lead

Bursa Postgraduate Hospital

OTHER

NCT04507282 - Eosinophil and Anticoagulation in COVID-19 Patients | Biotech Hunter | Biotech Hunter